Acute Assessment of a Micro Multipolar Lead for Enhanced Cardiac Resynchronisation Therapy — AXONE-Acute

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Cardiac Resynchronisation Therapy Clinical Trial

Official title:
AXONE -Acute : Acute Assessment of a Micro Multipolar Lead for Enhanced Cardiac Resynchronisation Therapy

Status Completed

Clinical Trial Summary

Pilot study to evaluate the performance of a lead below 2 French with specific distal shape to deliver efficient LV pacing

n/a

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04376983` - Effect of Implant-based Telerehabilitation	N/A
Recruiting	`NCT02814942` - Prospective Evaluation of Asians With CRT for Heart Failure
Recruiting	`NCT04156412` - AXONE-Acute II: Acute Assessment of a Micro Multipolar Lead for Enhanced Cardiac Resynchronisation Therapy	N/A
Recruiting	`NCT00472238` - Effects of Endurance Training on Patients With Reduced Left Ventricular Ejection Fraction (LVEF) and Cardiac Resynchronisation Therapy Especially for Cardiac Arrhythmias	N/A